Cargando…
When is crossover desirable in cancer drug trials and when is it problematic?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961160/ https://www.ncbi.nlm.nih.gov/pubmed/29648572 http://dx.doi.org/10.1093/annonc/mdy116 |